naratriptan tablets launched in the us
Post on 12-Dec-2016
217 views
TRANSCRIPT
Narahiptan tablets launched in the US
MARKET NEWS
The tablet formulation of naratriptan ['Amerge'; Glaxo Wellcome] has been launched in the US for the acute treatment of migraine.
Naratriptan, a 5-HT1BIID agonist, has already been approved in 14 countries and will now be available in tho. TT~ "u,' 1 I()"~ .., 4\",,0' "'tr~nnth t-::.hl,:.t" ~ •• '"' ...... - t.4J ... -....~ -o"'.&&&b .., ..... "" •• 0 .... "'-..,._ .. ..,.
According to Glaxo Wellcome, naratriptan therapy is associated with a low rate of headache recurrence (between 19 and 28% within 24 hours), reports Marketletter.
'Amerge' is indicated for patients with migraine who have long-lasting or recurrent headaches or who are unable to tolerate other anti-migraine products.
Naratriptan launched in the USA. Marketletter 25: 21, 30 Mar 1998 _
1173-832419811132-000211$01.00° Adialnternlltionel Limited 1998. All righta.--wel
21
Inphanna-11 Apr 1998 No. 1132